Orion Oyj (ORNBV.HE)
18.60EUR
18 Jun 2013
€-0.13 (-0.69%)
€18.73
€18.72
€18.75
€18.47
330,756
329,401
€24.58
€13.99
About
Overall
| Beta: | 0.27 |
| Market Cap (Mil.): | €2,641.53 |
| Shares Outstanding (Mil.): | 141.26 |
| Dividend: | 1.30 |
| Yield (%): | 6.94 |
Financials
| ORNBV.HE | Industry | Sector | |
|---|---|---|---|
| P/E (TTM): | 12.98 | 31.05 | 31.28 |
| EPS (TTM): | 1.44 | -- | -- |
| ROI: | 39.04 | 19.56 | 18.90 |
| ROE: | 56.23 | 20.32 | 19.80 |
UPDATE 1-NORDIC STOCKS - Factors to watch on June 3
HELSINKI, June 3 - The following stocks may be affected by newspaper reports and other factors on Monday:
BRIEF-Orion Diagnostica to cut 80 jobs in Finland
HELSINKI, June 3 - Orion Oyj : * Orion Diagnostica's statutory co-operation negotiations completed * Says 60 persons of the company's personnel in Finland will be given a notice * Says in addition about 20 people will leave their positions due to a
BRIEF-Orion to issue a bond
HELSINKI, May 20 - Orion Oyj : * Orion Corporation is preparing to issue a bond * says is preparing to issue a EUR 100-150 million senior, unsecured bond that would mature in 5-7 years (Reporting by Helsinki Newsroom)
UPDATE 1-Orion profit falls on generic competition
* Generic competition increasing as patents expire (Adds bullets, company statement)
Orion profit falls as Parkinson's drug patents expire
HELSINKI, April 23 - Finnish drug maker Orion reported a fall in first-quarter profit, in line with expectations, due to the expiration of its patents for Parkinson's drugs.
UPDATE 1-NORDIC STOCKS - Factors to watch on April 10
HELSINKI, April 10 - The following stocks may be affected by newspaper reports and other factors on Wednesday:
BRIEF-Orion plans to cut 80 jobs in Finland
HELSINKI, April 10 - Orion Oyj : * Orion Diagnostica proposes co-operation negotiations on streamlining its
BRIEF-Orion applies to market asthma products in Europe
HELSINKI, March 21 - Orion Oyj : * Submitted a marketing authorisation application for Easyhaler asthma products
Richter signs development deal with Finland's Orion
BUDAPEST, March 12 - Hungary's leading drug producer Richter has signed a long-term research and development cooperation agreement with Finnish pharmaceuticals company Orion Corporation, Richter said in a statement on Tuesday.
UPDATE 1-Orion says new products to soften generics blow
HELSINKI, Feb 5 - Finnish drug maker Orion said sales of new products were helping to soften the blow of increasing generic competition for its Parkinson's drugs, forecasting stronger-than-expected sales for 2013.
Earnings vs.
Estimates
Analyst Research Reports
| Report Title | Price |
|---|---|
|
Provider: Reuters Investment Profile
|
$20.00
|
|
Provider: Wright Reports
|
$472.00
|
|
Provider: Thomson Reuters StreetEvents
|
$75.00
|
|
Provider: GlobalData
|
$125.00
|
|
Provider: GlobalData
|
$250.00
|
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

